Keyword: medication

  • Jockey Club chairman Stuart S. Janney III

    Janney Stands by Criticism of Pennsylvania

    A request by the Pennsylvania Dept. of Agriculture for Stuart Janney III to retract his recent criticisms of the Pennsylvania State Horse Racing Commission saw the Jockey Club chairman reiterate his disapproval Oct. 17.

  • Barbara Banke speaks at The Jockey Club Round Table

    Optimism for Horseracing Integrity Act at Round Table

    The 65th annual Round Table Conference on Matters Pertaining to Racing Aug. 13 in Saratoga Springs, N.Y., closed out with an update and a rally cry for legislation that would overhaul oversight of horse racing’s drug testing and medication rules.

  • Cover art for longform about Tom Smith

    Silent Tom's Atomizer

    The investigation of popular trainer Tom Smith, of Seabiscuit fame, after ephedrine was discovered in an atomizer he used before a 1945 race saw the “absolute insurer” rule put to an early test.

  • CHRB Approves Medication Conditions for Breeders' Cup

    In the aftermath of Masochistic's disqualification from the 2016 TwinSpires Breeders' Cup Sprint (G1), Del Mar and the Breeders' Cup asked the California Horse Racing Board May 25 for permission to avoid such an event in the 2017 World Championships.

  • Jeff Novitzky speaks at Aug. 14 Round Table Conference

    Call Issued for Consensus on Medication Plan

    The need for consensus among major stakeholders in horse racing in regard to drug testing and enforcement of penalties again was a major theme during The Jockey Club Round Table Conference held Aug. 14 in Saratoga Springs, N.Y.

  • Jim Gagliano

    Integrity, Innovation on Round Table Agenda

    The Jockey Club will use its Aug. 14 Round Table Conference to discuss ways it can build upon existing programs, and also will continue its advocacy for federal legislation regarding equine medication and drug testing.

  • Racing at Sunland Park in New Mexico

    NM Meeting Designed to Bring About Change

    The New Mexico racing and breeding industry recently held the first of what could become a regular series of meetings to address common issues, including equine medication and drug testing protocol.

  • Mountaineer

    Mountaineer's Leading Trainer Suspended

    Edward Clouston, runaway leader in the trainers’ standings at Mountaineer Racetrack, has been fined $1,500 and suspended 15 days for a medication violation, with an additional 30 days added as a result having two offenses within a 365-day period.

  • Trainer Steve Miyadi (center) with Run for Retts in the Del Mar winner's circle in 2015

    Miyadi Suspended by CHRB After Drug Test

    The California Horse Racing Board announced July 21 that trainer Steve Miyadi will be suspended 30 days after one of his horses tested for levels of methamphetamine and amphetamine that exceeded allowed limits.

  • MD, DE Rule Glaucine Positives Contamination

    The Maryland Racing Commission June 27 voted unanimously to treat a spate of recent positive tests for glaucine as environmental contamination, to release purse funds that had been withheld in some cases, and to hold harmless the affected trainers.

  • Joe De Francis

    Humane Society Forms Horse Racing Council

    The Humane Society of the United States, a member of a group that supports federal legislation that would grant USADA authority over equine medication policy and drug testing, has formed a horse racing council to promote animal welfare standards.

  • John Servis

    Servis Questions Parx Clenbuterol Positives

    John Servis, trainer of Kentucky Oaks (gr. I) winner Cathryn Sophia, is questioning three clenbuterol positives in his horses in April and May at Parx Racing, including one for a 3-year-old filly he said had never been administered the medication.

  • Marcus Vitali

    Vitali Seeks to Get Florida License Restored

    Trainer Marcus Vitali moved his stable from Gulfstream to Laurel, but he must deal with positive tests for Class 4 and Class 5 medications in Florida before the Maryland Jockey Club will allow him to continue racing horses.

  • Churchill Downs

    KHRC, Churchill Outline Testing, Security

    The Kentucky Horse Racing Commission and Churchill Downs have outlined protocol for medication, drug testing, security, and safety during Kentucky Derby week, including out-of-competition testing and the monitoring of horses.

  • Racing industry stakeholders address Congressional Horse Caucus April 28

    Horse Caucus Takes Testimony on Drug Bill

    Members of the Congressional Horse Caucus April 28 discussed the pros and cons of legislation that would grant the United States Anti-Doping Agency oversight of equine medication policy, testing, and enforcement.

  • Alan Foreman

    Adoption of Penalty System Considered Key

    Of the four parts of the National Uniform Medication Program, the multiple medication violation penalty system has been adopted by the lowest number of jurisdictions. But one official April 11 said he expects that to change.

  • Ed Martin at the RCI conference

    Path Forward for Racing Debated at Meeting

    An April 7 town hall meeting organized by the Association of Racing Commissioners International revealed consensus on the need for a central governing structure for horse racing, but little agreement on how to achieve it.

  • 'Egregious' Levels of Cobalt Trigger Bans

    Six Standardbred trainers in New York were suspended after horses in their care registered extremely high levels of cobalt, and for three of them, the levels were so high the NYSGC issued 10-year bans per incident.

  • Alan Foreman

    Foreman Believes in Science Behind Thresholds

    Thoroughbred Horsemen's Association chairman Alan Foreman is confident a 2015 decision not to pursue a medication overage case against trainer Todd Pletcher won't negatively impact the National Uniform Medication Program.

  • Trainer Peter Moody (left) celebrates with jockey Brad Rawiller after Flamberge's win in the Mitchelton Wines William Reid Stakes.

    Moody Goes Out a Winner in Group I Stakes

    Trainer Peter Moody, who said he will give up training and not appeal a six-month ban for a cobalt positive, went out a winner March 24 when the 6-year-old millionaire gelding Flamberge won the group I William Reid Stakes.

  • Ohio has conducted research on cobalt

    Ohio Adopts Cobalt Rules, to Begin Testing

    Regulations for cobalt have been adopted by the Ohio State Racing Commission, which will begin testing April 15 for the naturally occurring mineral that can adversely affect the equine health when given in large doses.

  • CHRB, Trainers Argue Over Drug Disclosures

    A California Horse Racing Board Medication and Track Safety Committee meeting was often contentious at Santa Anita Park March 16, when topics regarding drug use and documentation were discussed.

  • United States Capitol building

    Federal Medication Bill Picks Up Co-Sponsors

    Federal legislation that would grant the United States Anti-Doping Agency oversight of equine medication policy, testing, and enforcement has picked up additional sponsors in the U.S. House, officials said March 14.

  • Court Rules Against Los Alamitos Drug Rules

    The Los Angeles Superior Court determined March 10 that Los Alamitos Race Course house rules on clenbuterol and albuterol testing in Quarter Horse races violated state laws and that the CHRB should not have allowed the rules.

  • AQHA Suspends Penalty System Pending Review

    The American Quarter Horse Association said it remains committed to addressing misuse of medication in racing but a need for more resources has led it to suspend use of its multiple medication violation system pending review.

  • Penn National Race Course in Pennsylvania

    PA Racing 'Reform' Law Signed by Governor

    Legislation designed to modernize horse racing in Pennsylvania was signed into law Feb. 23 by Gov. Tom Wolf, who last fall threatened to shut down the industry because it couldn't pay for regulation.

  • RMTC Outlines Procedures on Drug Guidelines

    The Racing Medication and Testing Consortium Feb. 19 issued an overview of its procedures in setting withdrawal times and drug-testing threshold levels after the National HBPA said it would pursue its own research.